Clearpoint Neuro Inc (CLPT) — Cash Flow-to-Debt Ratio
Clearpoint Neuro Inc (CLPT) has a Cash Flow-to-Debt Ratio of -0.17x as of December 2025, meaning its operating cash flow of $-12.08 Million could theoretically repay 0% of its total liabilities ($69.73 Million) in one year. See Clearpoint Neuro Inc (CLPT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearpoint Neuro Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Clearpoint Neuro Inc across 15 annual periods. Also explore Clearpoint Neuro Inc (CLPT) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Clearpoint Neuro Inc (2011–2025)
Year-by-year debt coverage analysis for Clearpoint Neuro Inc. For market capitalisation and broader financial context, see Clearpoint Neuro Inc (CLPT) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.34x | $-23.93 Million | $69.73 Million | ▲ +47.1% |
| 2024 | -0.65x | $-8.95 Million | $13.80 Million | ▼ -1.6% |
| 2023 | -0.64x | $-13.72 Million | $21.49 Million | ▲ +26.5% |
| 2022 | -0.87x | $-16.17 Million | $18.60 Million | ▼ -14.9% |
| 2021 | -0.76x | $-12.70 Million | $16.79 Million | ▼ -162.8% |
| 2020 | -0.29x | $-7.81 Million | $27.14 Million | ▲ +25.9% |
| 2019 | -0.39x | $-2.85 Million | $7.34 Million | ▲ +46.8% |
| 2018 | -0.73x | $-4.63 Million | $6.35 Million | ▲ +1.7% |
| 2017 | -0.74x | $-5.99 Million | $8.07 Million | ▼ -4.1% |
| 2016 | -0.71x | $-5.82 Million | $8.16 Million | ▲ +0.2% |
| 2015 | -0.71x | $-8.64 Million | $12.08 Million | ▼ -33.0% |
| 2014 | -0.54x | $-7.25 Million | $13.49 Million | ▼ -1.7% |
| 2013 | -0.53x | $-7.78 Million | $14.71 Million | ▲ +19.7% |
| 2012 | -0.66x | $-7.43 Million | $11.29 Million | ▼ -162.5% |
| 2011 | -0.25x | $-6.24 Million | $24.87 Million | — |